The pharmaceutical industry, with LIF (The Swedish Association of Pharmaceutical Industry) as the driving force, has decided to use GS1’s standards for the identification and labelling of products. Starting 9 February 2019, prescription drugs must be identified and serialised.
When the pharmacy scans products at its checkout, an automatic check will be made against supplier data so that counterfeit packages of prescription drugs do not reach the market. For this purpose, a 2D barcode will be used, GS1 DataMatrix.
Case study AstraZeneca: GS1 standards help us attack counterfeiting (pdf)
Read more about different sectors on our global website
Do you have questions regarding GS1 and healthcare? Please contact our sector manager Mats Björkqvist, tel +46 8 50 10 10 34